MILAN, May 29, 2018 /PRNewswire/ -- Zcube, Research Venture of Zambon Pharmaceutical Group, has launched the third edition of the international Open Accelerator programme, with a specific focus on the areas of the CNS and the Respiratory System, including rare diseases. The Call...
from PR Newswire: //https://ift.tt/2IWjKQu
No comments:
Post a Comment